@article{1e8bcb72d7f3467287bf480f1029e9b0,
title = "Prior Antibodies to Infliximab or Adalimumab Are Related to Immunogenicity to Vedolizumab in Patients With Inflammatory Bowel Disease",
keywords = "Humans, Adalimumab/adverse effects, Infliximab/adverse effects, Antibodies, Monoclonal, Humanized/therapeutic use, Inflammatory Bowel Diseases/drug therapy, Colitis, Ulcerative, Tumor Necrosis Factor-alpha",
author = "Konstantinos Papamichael and {Vande Casteele}, Niels and Abraham, {Bincy P.} and Timothy Ritter and Anjali Jain and Cheifetz, {Adam S.}",
year = "2023",
month = oct,
doi = "10.1016/j.cgh.2022.10.037",
language = "English (US)",
volume = "21",
pages = "2978--2980.e2",
journal = "Clinical Gastroenterology and Hepatology",
issn = "1542-3565",
publisher = "W.B. Saunders Ltd",
number = "11",
}